Novo Nordisk CEO steps down amid market challenges, including competition from Eli Lilly's rival drug and setbacks with Novo Nordisk's obesity treatments.
Fed plans workforce reduction, aligning with government efficiency efforts championed by Trump and Musk.
Verizon ends diversity programs to gain FCC approval for Frontier merger, raising concerns over rollback of corporate DEI initiatives.
Novo Nordisk CEO steps down amid market challenges, including competition from Eli Lilly's rival drug and setbacks with Novo Nordisk's obesity treatments.
Fed plans workforce reduction, aligning with government efficiency efforts championed by Trump and Musk.
Verizon ends diversity programs to gain FCC approval for Frontier merger, raising concerns over rollback of corporate DEI initiatives.